3643companies in the directory 1104ISIN verified against the check digit 7exchanges 14sectors No real-time quotes — a reference work, not a trading platform3643companies in the directory 1104ISIN verified against the check digit 7exchanges 14sectors No real-time quotes — a reference work, not a trading platform
DE · EN Newsletter
Biotech & Pharma Symbolbild · KI-generiert
Biotech & Pharma RMTI

Rockwell Medical Inc.

RMTI NASDAQ US7743743004 Biotech & Pharma

Stock factsheet

TickerRMTI
ExchangeNASDAQ
ISINUS7743743004
WKN
SectorBiotech & Pharma
Size class Nano Cap
Market capitalisation 28 Mio. USD As of 2026-08-03

Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.

Company profile

Rockwell Medical is a US pharmaceutical company specialising in products for dialysis therapy. Its core business covers the manufacture and distribution of haemodialysis concentrates and iron preparations for the treatment of iron deficiency anaemia in dialysis patients. The company supplies primarily dialysis clinics in the United States.

Short profile generated automatically and checked for plausibility. A full editorial profile follows once we cover the company.

Share price

Price data from TradingView, possibly delayed. Not investment advice.

Comparable companies

Companies in the Biotech & Pharma sector of a similar size.

CompanyTickerExchangeMarket cap
Rockwell Medical Inc.RMTI NASDAQ28 Mio. USD
Microbix Biosystems Inc. MBXTSX 29 Mio. USD
TempraMed Technologies Ltd. VIVICSE 27 Mio. USD
Sernova Biotherapeutics Inc. SVATSX 30 Mio. USD
Nova Leap Health Corp. NLHTSXV 27 Mio. USD
Optimi Health Corp OPTICSE 27 Mio. USD
Thiogenesis Therapeutics Corp. TTITSXV 27 Mio. USD

Investor Relations

Annual reports Not recorded yet
Investor presentation Not recorded yet
Analyst coverage Not recorded yet

We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.

Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.